To the Editor: Dr Shelton and colleagues1 concluded that "St John's wort was not effective
for treatment of major depression." These authors may have been overly skeptical
in interpreting their data. In the intent-to-treat analysis, according to
the study's response criterion, 26.5% of subjects receiving St John's wort
vs 18.6% of patients in the placebo group responded to treatment (P = .15), and according to the study's remission criterion, 14.3% vs
4.9% showed remission (P = .02). If one evaluates
this trial in the context of other similar studies, it is noteworthy that
the comparisons of St John's wort vs placebo in this study is in the same
direction as studies with a positive outcome, although it does not reach statistical
significance. What is surprising about these data is the low response rate
to placebo. A placebo response of 20% to 30% is routine in studies of depression.2 Thus, an equally reasonable conclusion is that
St John's wort was perhaps better than placebo in the treatment of major depression.
A third arm with an established antidepressant might have resolved these difficulties.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 2
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.